| dc.contributor.author | Cengiz, K | |
| dc.contributor.author | Gunaydin, M | |
| dc.contributor.author | Bedir, A | |
| dc.contributor.author | Pekbay, A | |
| dc.date.accessioned | 2020-06-21T15:53:04Z | |
| dc.date.available | 2020-06-21T15:53:04Z | |
| dc.date.issued | 1998 | |
| dc.identifier.issn | 0028-2766 | |
| dc.identifier.uri | https://doi.org/10.1159/000045095 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/22538 | |
| dc.description | WOS: 000075230300013 | en_US |
| dc.description | PubMed: 9689165 | en_US |
| dc.description.abstract | A possible agent for human non-A-E hepatitis has been identified and named hepatitis G virus (HGV). HGV is also a flavivirus, and the clinical characteristics and risk factors of HGV infection may be similar to those of hepatitis C virus infection. Hepatitis C virus infection may manifest as a primary glomerulonephritis. The aim of this study is to evaluate the prevalence of serum HGV RNA in 98 adult patients with biopsy-proven glomerular diseases. We found that only 3 patients (3%) out of 98 with primary glomerulonephritis had HGV RNA. One of 59 (1.7%) healthy controls was serum HGV RNA positive (p > 0.05). The prevalence of serum HGV RNA was low in the patients with primary glomerulonephritis. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Karger | en_US |
| dc.relation.isversionof | 10.1159/000045095 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | hepatitis G virus | en_US |
| dc.subject | glomerular diseases | en_US |
| dc.title | Low prevalence of hepatitis G virus antibodies in glomerular diseases | en_US |
| dc.type | article | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 79 | en_US |
| dc.identifier.issue | 4 | en_US |
| dc.identifier.startpage | 472 | en_US |
| dc.identifier.endpage | 473 | en_US |
| dc.relation.journal | Nephron | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |